"The newly set up Vigilance Commission has been asked to enquire into this. Other wings of the government are also conducting parallel enquiries to ensure that all the facts are made available," Omar told reporters.
Kashmir has been rocked by protests over the supply of spurious drugs to government hospitals in the Valley. The scam came to light when laboratory tests revealed that an anti-biotic supplied to various hospitals contained zero amount of 'Amoxycillin' against the claimed 500 milligrams and other tests showed traces of particulate matter in some medicines.
"Both the ministers are working together to ensure that the lacunae in the system is completely plugged and such incidents of fake drugs being made available to the patients are entirely and completely stopped immediately," Omar said.
Omar said the enquiry into the scam will be "complete and total" and will not stop at any level.
"It will ensure that responsibility, wherever it lies, will be fixed and we will make sure that this is not repeated," he added.
"The government testing laboratories do not have the capacity to deal with the number of tests that need to be conducted. Therefore, we are looking at the possibility of private-public partnership in establishing laboratories for testing the drugs and medicines that are coming into the state," he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
